BioSpace News Archive

Drug Development

Athenex Receives Positive Feedback From FDA on the Design of Phase III Clinical Trial for Oraxol

The Oraxol Phase III clinical study is a randomized controlled international clinical trial investigating the superiority of Oraxol over intravenous paclitaxel in the treatment of patients with metastatic breast cancer.

January 16, 2018
·
5 min read
Drug Development

RedHill Biopharma Announces Final Results From Phase II Study With BEKINDA for IBS-D

The company confirmed that the Phase II study with BEKINDA 12 mg successfully met its primary endpoint.

January 16, 2018
·
8 min read
Business

Interface People (IPeople) and Novaseek Research Announce Partnership

The deal will provide Novaseek’s CDNR platform users with an improved experience while expanding Interface People’s customer-centered health IT products, services and solutions to compound growth plans.

January 16, 2018
·
2 min read
Gyros Protein Technologies Introduces Multi-Species Kit for Toxicokinetic Studies

The new Gyrolab Generic TK Kit adds to a growing menu of ready-to-use kits, and allows researchers to more efficiently quantify human therapeutic antibodies (IgG) in automated, nanoliter-scale Gyrolab xP and Gyrolab xPlore systems.

January 16, 2018
·
2 min read
CEVEC to Introduce New Helper-Free AAV Packaging Cell Line for Scalable Stable Gene Therapy Vector Production at the Phacilitate Cell & Gene Therapy World Conference

Based on its proprietary CAP-GT manufacturing platform of suspension cell lines, CEVEC has successfully developed a novel AAV stable production system that allows for easy scale up in all existing bioreactor formats.

January 16, 2018
·
4 min read
Business

Assure Holdings Appoints Peter Csapo as Chief Financial Officer

Former CFO Frank Iadipaolo will stay with the Company during an interim period to assist with the transition.

January 16, 2018
·
5 min read
Arbutus Announces Closing of the Second Tranche of a $116M Strategic Investment From Roivant Sciences

The Tranche 2 closing represents the second of two tranches of Preferred Shares issued to Roivant.

January 16, 2018
·
2 min read
Antibiotic Resistance: Pherecydes Pharma Raises €8.7M ($10.3M)

With this financial support, the company plans to produce phages for compassionate use in accordance with GMP.

January 16, 2018
·
9 min read
CV Sciences, Inc. Repays Installment Obligation on Convertible Debt

On January 5, 2018, the Company made payment to the holder of the Note equal to $100,000 and the lender accepted this payment.

January 16, 2018
·
2 min read
Deals

Skyline Medical Completes Purchase of Preferred Stock in Helomics Corporation

In addition, Skyline has the right to convert a previous $500,000 loan to Helomics into a further 5% equity stake, which would bring its total ownership to 25%.

January 16, 2018
·
5 min read